Executive Sponsors

Iovance
IQVIA

Supporting & Educational Partners

Alliance for Regenerative Medicine (ARM)
California Life Sciences Association (CLSA)
Cancer Research Institute CRI
Center for Biotechnology (CFB)
Journal of Immunotherapy and Precision Oncology (JIPO)
Society for Immunotherapy of Cancer (SITC)

Media Partners

Big4Bio
CIMT
Clinical trial vendors
Gene Therapy Net
Life Science Leader
MedTech Outlook

2020 Speaking Faculty

  • Jeff Allen, PhD

    President & CEO

    Friends of Cancer Research

  • Andrew Baum, MD

    Head of Global Healthcare; Managing Director, Equity Research

    Citi

  • Sharon Benzeno

    Sharon Benzeno, PhD

    SVP, Drug Discovery

    Adaptive Biotechnologies

  • Anne Chew

    Anne Chew, PhD

    Executive Deputy Director, Center for Cellular Immunotherapies

    University of Pennsylvania

  • Boro Dropulic

    Boro Dropulić, PhD

    Chief Science Officer & General Manager

    Lentigen

  • Mark Dudley

    Mark Dudley, PhD

    SVP, Early Stage Development

    Adaptimmune

  • Fardis_Maria_NEW

    Maria Fardis, PhD

    President and CEO

    IOVANCE Biotherapeutics

  • Mitchell Finer

    Mitchell Finer, PhD

    CSO, President and Executive Partner

    ElevateBio / ElevateBio Basecamp / MPM Capital

  • Stephanie Goff

    Stephanie Goff, MD

    Associate Research Physician, Surgery Branch

    National Cancer Institute, NIH

  • Patrick Hanley

    Patrick Hanley, PhD

    Director, GMP for Immunotherapy / Associate Professor

    Children's National Medical Center / George Washington University

  • Ramy Ibrahim

    Ramy Ibrahim, MD

    Chief Medical Officer and VP, Clinical Development

    Parker Institute for Cancer Immunotherapy

  • Janet Lambert

    Janet Lynch Lambert

    CEO

    Alliance for Regenerative Medicine

  • Chris Learn

    Chris Learn, PhD

    Senior Therapeutics Strategy Director, Cell and Gene Therapy

    IQVIA

  • Cheng Liu

    Cheng Liu, PhD

    Founder & CEO

    Eureka Therapeutics

  • Brad Loncar

    Brad Loncar

    CEO

    Loncar Investments

  • Vanessa Lucey

    Vanessa Lucey, PhD

    Director, CRI Venture Fund and Clinical Accelerator

    Cancer Research Institute

  • Crystal Mackall

    Crystal Mackall, MD

    Professor of Pediatrics and Medicine; Director, Stanford Center for Cancer Cell Therapy; Director, Parker Institute for Cancer Immunotherapy at Stanford; Associate Director, Stanford Cancer Institute

    Stanford University School of Medicine

  • Peter Marks

    Peter Marks, MD, PhD

    Director

    Center for Biologics Evaluation and Research (CBER), FDA

  • Adrian McKemey, PhD

    Managing Director and Head of R&D Strategy Solutions

    IQVIA

  • Amanda Murphy

    Amanda Murphy

    Managing Director, Biotechnology Research

    BTIG

  • Jill O'Donnell-Tormey

    Jill O’Donnell-Tormey, PhD

    CEO & Director, Scientific Affairs

    Cancer Research Institute (CRI)

  • Mark O'Hara

    Mark O’Hara, MD

    Assistant Professor of Medicine

    University of Pennsylvania

  • Paglia_Michael

    Michael Paglia

    VP, CMC Operations

    ElevateBio

  • Saul Priceman

    Saul Priceman, PhD

    Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation

    City of Hope

  • Naiyer Rizvi

    Naiyer Rizvi, MD

    Price Family Professor of Medicine; Director, Thoracic Oncology; Co-Director, Cancer Immunotherapy

    Columbia University Irving Medical Center

  • Alberto Santagostino

    Alberto Santagostino

    SVP, Global Head of Cell & Gene Technologies

    Lonza Pharma & Biotech

  • Aiman Shalabi

    Aiman Shalabi, PharmD

    VP R&D, Cell and Gene Therapies

    GSK

  • Sharon_Elad

    Elad Sharon, MD

    Senior Investigator, Cancer Therapy Evaluation Program (CTEP)

    National Cancer Institute (NCI)

  • Raluca Verona

    Raluca Verona, PhD

    Senior Director, Head of Immune Oncology Translational Research

    Janssen R&D